average previous covid i9 infection status, it may be a different covid i9 vaccination status, so we have to really keep those in mind. there s also going to be a delay in the number of cases and hospitalisations. we may still be seeing a little bit of that. but it is also really important to remember that er d have to decrease the severity of this outcome by a factor that s proportional to its increased transmissibility for that to be less of an impact on the health care system, and unfortunately the transmissibility is so high that we will wind up seeing an increase in hospitalisations, and that s even if the proportion of those cases is fewer than we have seen for other variants. given what you said, what is the best way to decrease the transmissibility, as you ve just described, so we don t get to that situation? i think we have to go back to the swiss cheese model of preventing respiratory transmission of covid i9. so one slice of the swiss cheese is vaccines. we need global equit
is that encouraging or a possible model we can use for other countries? it s very helpful information, but it has to be taken with several grains of salt. so one thing to keep in mind is that the population of south africa may be of a different type than the population of another country. it may be a different average age, it may be a different average previous covid i9 infection status, it may be a different covid i9 vaccination status, so we have to really keep those in mind. there s also going to be a delay in the number of cases and hospitalisations. we may still be seeing a little bit of that. but it is also really important to remember that er d have to decrease the severity of this outcome by a factor that s proportional to its increased transmissibility for that to be less of an impact on the health care system, and unfortunately the transmissibility is so high that we will wind up seeing an increase in hospitalisations, and that s even if the proportion of those cases is fewer
transmissibility. indeed. dr sundaram. transmissibility. indeed. dr sundaram, i transmissibility. indeed. dr sundaram, ijust transmissibility. indeed. dr sundaram, i just want - transmissibility. indeed. dr sundaram, i just want to i transmissibility. indeed. drl sundaram, i just want to put transmissibility. indeed. dr - sundaram, i just want to put you some of the early data coming in from south africa, and i want to copy that it is indeed early data but it seems to suggest that while infections are on the rise, hospitalisations are low. is that encouraging or impossible model we can use for other countries? i5 encouraging or impossible model we can use for other countries?- can use for other countries? is very helful can use for other countries? is very helpful information, can use for other countries? is very helpful information, but can use for other countries? is very helpful information, but it - can use for other countries? is very helpful information, but it has -
proportional to its increased transmissibility for that to be less of an impact on the health care system, and unfortunately the christmas ability is so high that we will wind up seeing an increase in hospitalisations, and that s even if the proportion of those cases is fewer than we have seen for other variants b transmissibility is so high. hih. , a, hih. ., a, , high. given what you said, what is the best way high. given what you said, what is the best way to high. given what you said, what is the best way to decrease - high. given what you said, what is the best way to decrease the - the best way to decrease the transmissibility, as you ve described, so we don t get to that situation? i described, so we don t get to that situation? ~ ., ., ., situation? i think we have to go back to the situation? i think we have to go back to the swiss situation? i think we have to go back to the swiss cheese - situation? i think we have to goi back to the swiss cheese model situation?
is physical distancing as much as possible, and so hopefully we can combine these measures that we do no work, so that we can reduce transmissibility little bit, but it is good to be a very telling time going to be a very challenging time. dr sundaram, are you encouraged by the fact that some boosters at least two appear to work? and what is the medical advice around that? i am very encouraged medical advice around that? i am very encouraged by medical advice around that? i n very encouraged by that. so the idea is that when you boost the amount of antibodies that you have with a third dose, for example, after two mrna doses of a covid i9 vaccine, that increase in antibody plus the increase in t cell activity could potentially protect you more than your first two doses. that s really great news, but always on my mind is, who has access to that third dose? unfortunately, farke min people have stood on had access to their first dose, so people have stood on had access to theirfir